These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases. Dardik H; Wengerter K; Qin F; Pangilinan A; Silvestri F; Wolodiger F; Kahn M; Sussman B; Ibrahim IM J Vasc Surg; 2002 Jan; 35(1):64-71. PubMed ID: 11802134 [TBL] [Abstract][Full Text] [Related]
6. A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb. Dardik H; Miller N; Dardik A; Ibrahim I; Sussman B; Berry SM; Wolodiger F; Kahn M; Dardik I J Vasc Surg; 1988 Feb; 7(2):336-46. PubMed ID: 3123718 [TBL] [Abstract][Full Text] [Related]
7. Early aneurysmal degeneration of human umbilical vein bypass grafts. Layer GT; King RB; Jamieson CW Br J Surg; 1984 Sep; 71(9):709-10. PubMed ID: 6478164 [TBL] [Abstract][Full Text] [Related]
8. Biodegradation and aneurysm formation in umbilical vein grafts. Observations and a realistic strategy. Dardik H; Ibrahim IM; Sussman B; Kahn M; Sanchez M; Klausner S; Baier RE; Meyer AE; Dardik II Ann Surg; 1984 Jan; 199(1):61-8. PubMed ID: 6691733 [TBL] [Abstract][Full Text] [Related]
9. Prediction of aneurysm formation in vascular grafts of biologic origin. Hamilton G; Megerman J; L'Italien GJ; Warnock DF; Schmitz-Rixen T; Brewster DC; Abbott WM J Vasc Surg; 1988 Mar; 7(3):400-8. PubMed ID: 2831410 [TBL] [Abstract][Full Text] [Related]
10. Reoperation for complications of stabilized human umbilical vein grafts. Jarrett F; Hirsch SA Am J Surg; 1989 Nov; 158(5):438-42. PubMed ID: 2817226 [TBL] [Abstract][Full Text] [Related]
11. Biodegradation of glutaraldehyde-tanned human umbilical vein grafts. Sato O; Okamoto H; Takagi A; Miyata T; Takayama Y Surg Today; 1995; 25(10):901-5. PubMed ID: 8574057 [TBL] [Abstract][Full Text] [Related]
12. Human umbilical vein grafts as infrainguinal bypasses: long-term clinical follow-up and pathological investigation of explanted grafts. Batt M; Gagliardi JM; Avril G; Guzman R; Guidoin R; Hassen-Khodja R; Marois M; Le Bas P Clin Invest Med; 1990 Aug; 13(4):155-64. PubMed ID: 2208831 [TBL] [Abstract][Full Text] [Related]
13. A clinicopathologic study of aneurysm formation of glutaraldehyde-tanned human umbilical vein grafts. Dardik H; Turner R J Vasc Surg; 1990 Aug; 12(2):221-2. PubMed ID: 2381033 [No Abstract] [Full Text] [Related]
14. Glutaraldehyde pre-treated human saphenous and umbilical veins as xenogeneic small vessel substitutes and shunts in dogs. Harjula A Ann Chir Gynaecol; 1981; 70(1):11-7. PubMed ID: 7259055 [TBL] [Abstract][Full Text] [Related]
15. Aneurysm formation in modified human umbilical vein grafts. Strobel R; Boontje AH; Van Den Dungen JJ Eur J Vasc Endovasc Surg; 1996 May; 11(4):417-20. PubMed ID: 8846174 [TBL] [Abstract][Full Text] [Related]
16. Human umbilical cord vein as arterial substitute in the dog. Karvonen E; Harjula A; Meurala H; Harjola PT Ann Chir Gynaecol; 1981; 70(2):61-4. PubMed ID: 6459050 [TBL] [Abstract][Full Text] [Related]
17. Comparison of platelet adherence and aggregation in modified human umbilical vein and autogenous vein grafts. Roedersheimer LR; Feins RH; Schwartz SI; DeWeese JA; Green RM Am J Surg; 1980 Nov; 140(5):591-5. PubMed ID: 7435812 [TBL] [Abstract][Full Text] [Related]
18. Aneurysm formation in human umbilical vein grafts. Giordano JM; Keshishian JM Surgery; 1982 Mar; 91(3):343-5. PubMed ID: 7058515 [No Abstract] [Full Text] [Related]
19. Histological study of glutaraldehyde-processed vascular grafts of biological origin. Harjula A; Nickels J; Mattila S Ann Chir Gynaecol; 1980; 69(6):256-62. PubMed ID: 7212601 [TBL] [Abstract][Full Text] [Related]